386 related articles for article (PubMed ID: 29107786)
1. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.
Wu LT; Zhu H; Mannelli P; Swartz MS
Drug Alcohol Depend; 2017 Aug; 177():153-162. PubMed ID: 28599214
[TBL] [Abstract][Full Text] [Related]
3. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
[No Abstract] [Full Text] [Related]
5. DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles.
Kerridge BT; Pickering R; Chou P; Saha TD; Hasin DS
Addict Behav; 2018 Jan; 76():52-60. PubMed ID: 28755613
[TBL] [Abstract][Full Text] [Related]
6. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities.
Boyd CJ; Veliz PT; McCabe SE
Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867
[No Abstract] [Full Text] [Related]
7. Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.
Khan SS; Secades-Villa R; Okuda M; Wang S; Pérez-Fuentes G; Kerridge BT; Blanco C
Drug Alcohol Depend; 2013 Jun; 130(1-3):101-8. PubMed ID: 23182839
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002 and 2019.
Askari MS; Keyes KM; Mauro PM
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109154. PubMed ID: 34741874
[TBL] [Abstract][Full Text] [Related]
9. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates.
Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
Psychiatry Res; 2013 Oct; 209(3):459-65. PubMed ID: 23312479
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being.
Butterworth P; Slade T; Degenhardt L
Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194
[TBL] [Abstract][Full Text] [Related]
11. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use disorder among veterans: Comorbidity and mental health treatment utilization.
Ecker AH; Lang B; Hogan J; Cucciare MA; Lindsay J
J Subst Abuse Treat; 2020 Feb; 109():46-49. PubMed ID: 31856950
[TBL] [Abstract][Full Text] [Related]
13. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
Compton WM; Han B; Jones CM; Blanco C
Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
[TBL] [Abstract][Full Text] [Related]
14. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
[TBL] [Abstract][Full Text] [Related]
15. Facilitators and barriers in treatment seeking for cannabis dependence.
van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
Drug Alcohol Depend; 2013 Dec; 133(2):776-80. PubMed ID: 24035185
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.
Bonn-Miller MO; Harris AHS; Trafton JA
Psychol Serv; 2012 Nov; 9(4):404-416. PubMed ID: 22564034
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use disorder treatment barriers and facilitators among veterans with PTSD.
Bujarski SJ; Galang JN; Short NA; Trafton JA; Gifford EV; Kimerling R; Vujanovic AA; McKee LG; Bonn-Miller MO
Psychol Addict Behav; 2016 Feb; 30(1):73-81. PubMed ID: 26618794
[TBL] [Abstract][Full Text] [Related]
18. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial functioning among regular cannabis users with and without cannabis use disorder.
Foster KT; Arterberry BJ; Iacono WG; McGue M; Hicks BM
Psychol Med; 2018 Aug; 48(11):1853-1861. PubMed ID: 29173210
[TBL] [Abstract][Full Text] [Related]
20. Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study.
Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
Depress Anxiety; 2019 Nov; 36(11):1036-1046. PubMed ID: 31356731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
